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As people age, the prevalence of a variety of health-
related symptoms commonly increase, such as: joint 
pain, decreased muscle mass, fatigue, anxiety and 
depression, and memory loss.  The propensity for and 
the disease severity for neurodegenerative diseases such 
as Parkinson’s Disease, Alzheimer’s Disease, and stroke 
also increase with age [1-5].  Mechanisms for this age-
associated phenomenon are currently unknown; 
however, females experience higher levels of neuro-
protection than males until they reach menopause [6-7].  
Post-menopause, this protection from neurologic 
disease diminishes resulting in lower protection than 
their male counterparts.  This loss of protection may be 
one mechanism in which females have a higher 
incidence and severity of stroke and neurodegenerative 
diseases [7-8].  Because females experience a sudden 
drop in estrogen levels during menopause [9], it has 
been hypothesized that hormones may play a role  in the  
 
neuroprotection noted early in female life. Furthermore, 
we propose that gender is an important factor to 
consider when evaluating the aging process.   
 
Hormones such as estrogen and progesterone are tissue-
specific signaling molecules that can regulate the 
activity of the cerebral cortex, hippocampus, and 
amygdala [10-11]. There are two isoforms of these 
receptors, ER-alpha and ER-beta, both of which 
regulate transcription [12].  Estrogen receptor beta is 
expressed differentially throughout the brain and has 
been implicated to have neuroprotective and tumor 
suppressing functions in the aging brain [11-17].  
Estrogen receptor-beta also signals within the mito-
chondria. This is relevant because mitochondrial 
alterations have been correlated to age- and region-
associated changes in learning and memory [7]; 
however, the mechanisms for these changes for both 
age and gender are unknown. Therefore, signaling 
cascades that are both down-stream of estrogen receptor 




















Recently  epidemiological  studies  suggest  females  lose  neuroprotection  from  neurodegenerative  diseases  as
they go  through menopause.  It has been hypothesized  that  this neuroprotection  is hormone‐dependent. The
current study characterized cell signaling molecules downstream of estrogen receptor beta that are known to
play a role in memory, PKC, ERK, and connexin‐43, in regions of the brain associated with memory decline in an
attempt  to  elucidate  significant  changes  that  occur  post‐estrus.  Total whole  cell  lysates were  compared  to
isolated  mitochondrial  protein  because  mitochondrial  function  is  known  to  be  altered  during  aging.  As
hypothesized, protein concentrations differed depending on age, gender, and brain region. Additionally, many
of  these  changes  occurred  within  mitochondria  but  not  within  whole  cell  lysates  indicating  that  these  are
epigenetic alterations. These findings accentuate the complexity of aging and provide  insight  into the gender‐
specific cellular processes that occur throughout this process. 
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beta and which regulate respiration within the 
mitochondria (PKC, cx43, and ERK) were quantified in 
brain regions that correspond to these mental tasks in 
order to begin to unravel this question. 
 
Signaling pathways downstream of the estrogen 
receptor-beta including protein kinase C (PKC), extra-
cellular signal-related kinase (ERK), and connexin were 
investigated in the current study.  These proteins signal 
within the mitochondria and have been implicated to 
have altered activity levels throughout the aging process 
[14-15, 18-25].  We hypothesize that changes in these 
estrogen-responsive proteins will be gender and brain 
region specific; providing insight into key signaling 
alterations that occur during the aging process.  
 
In this study, we characterized age-specific and gender-
specific changes that occur in five brain regions 
(cerebral cortex, hippocampus, amygdala, corpus 
callosum, and cerebellum). These regions were selected 
due to their known role in cognition, learning, and 
memory throughout the aging process.  Although all of 
these regions are involved in cognition and memory, 
which may decline with age; hormones have been 
shown to play an important role in the regulation of the 
cerebral cortex, hippocampus, and amygdala [11].  
Because brain regions respond to aging differentially 
[26], characterizing multiple regions provides a more 
complete description of changes that occur during the 
aging process, particularly as these regions are 
associated with different neurodegenerative diseases.  
This has been described in studies that have 
characterized gross structural, region-specific changes 
with age utilizing magnetic resonance imaging (MRI) 
and computed tomography (CT) scans. For example, the 
cerebral cortex, hippocampus, and cerebellum have 
been shown to significantly decrease in volume with 
age, while the amygdala undergoes very minimal 
anatomical change throughout the aging process [26-
28].  Although large-scale morphological changes have 
previously been shown to occur in several of the brain 
regions investigated, continued exploration into what 
alterations occur post-menopause may be vital to our 
understanding of the role of estrogen depletion in the 
loss of neuroprotection.  The aim of the current study 
was to characterize age-specific, gender-specific, and 
brain region-specific alterations in proteins downstream 
of the estrogen receptor. This study provides a 
foundation for further research, as well as, insight into 




Because neurodegenerative changes associated with 
Alzheimer’s disease have shown correlations with 
gender-dependent severity, brain regions were selected 
dependent upon their association with learning and 
memory. The cortex, hippocampus, cerebellum, and 
cortical white matter (corpus callosum), are all areas 
that have shown significant changes with age in human 
MRI studies.  These areas are also known to be highly 
susceptible in Alzheimer’s disease, one example of a 
disease in which the susceptibility and disease severity 
significantly increase post-menopause in females [7].  
 
Cerebral cortex – whole cell 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within the cortex over 
time and between genders, protein was isolated from the 
cerebral cortex of male and female rats at 4 timepoints 
throughout their lifespan (4 weeks, 3 months, 9 months, 
and 12 months of age; n = 3-4/gender/age). These 
timepoints in the rat lifespan correspond to youth to 
middle-age in humans (see Supplementary Table 1). 
The cerebral cortex was not subdivided into specific 
regions, and therefore contained the entire cortex for 
each brain.  Whole cell analysis for this region showed 
that the protein concentration of p-ERK was 
significantly different amongst the genders at nine 
months of age (Figure 1A, 1B; p = 0.008).  The male 
rats had sig-nificantly higher concentrations of p-ERK 
compared to the female counterparts (Figure 1A, 1B; p 
= 0.008).  Additionally, there was a trend for the 
twelve-month males to also have higher concentrations 
of p-ERK when compared to age-matched females 
(Figure 1A, 1B; p = 0.091).  Although this was not 
statistically significant there was a trend which may 
become significant if sample numbers were increased.  
The concentrations of p-PKC, PKC, ERK, p-cx43, and 
cx43 remained relatively constant regardless of gender 
or age (Figure 1A, 1C-G). A graphical depiction of this 
data can be seen in Figure 1. 
 
Cerebral cortex – mitochondrial isolation 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within cortical 
mitochondria over time and between genders, mito-
chondria were isolated from the cerebral cortex of male 
and female rats at 4 timepoints throughout their lifespan 
(4 weeks, 3 months, 9 months, and 12 months of age; n 
= 3/gender/age). The concentration of p-cx43 
significantly increased between four weeks of age and 
three months of age (Figure 2A & 2B; p = 0.028).  
There was also a significant difference between male 
and female rats at twelve months of age (Figure 2A & 
2C; p = 0.014), with the female rats having significantly 
lower concentrations.  Both genders experienced an 
increase in mitochondrial p-cx43 concentration as they 
aged from 4 weeks to 3 months of age (Figure 2A & 
2D; p = 0.028); however, at the post-estrus age between 
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9 months and 12 months, females experience a decrease 
resulting in significantly lower p-cx43 concentration 
compared to their male counterparts (Figure 2A & 2C; p 




















































Isolated mitochondria from the cortex also showed cx43 
was found to significantly change with age (Figure 2A 
& 2D).  Both genders experienced a significant increase 
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months of age (Figure 2A & 2D; p = 0.021).  This 
increase may be related to normal growth and estab-






















































To start to identify the role of estrogen in mitochondrial 
signaling, we analyzed the concentration of the estrogen 
receptor beta, which showed a strong trend for gender 




















































Figure  2.  Signaling  downstream  of  estrogen  in  the mitochondria  of  the  cerebral  cortex  across  age  and  gender.




www.aging‐us.com  2152  AGING 
female rats had a strong trend showing elevated con-
centrations of estrogen receptor beta when compared to 






















































The concentration of PKC remained relatively constant 
when comparing both age and gender in mitochondria 
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depiction of this data and the alterations demonstrated 
can be visualized in Figure 2. 
 
Hippocampus – whole cell 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within the hippocampus 
over time and between genders, whole cell lysate 
proteins were isolated from the hippocampus of male 
and female rats at 4 timepoints throughout their lifespan 
(4 weeks, 3 months, 9 months, and 12 months of age; n 
= 3-4/gender/age). Significant differences in p-PKC 
were found when comparing males and females at 
twelve months of age with males experiencing sig-
nificantly lower concentrations than their female 
counterparts (Figure 3A & 3B; p = 0.028).  Although 
not statistically significant, there was also a trend 
implicating gender differences at four weeks of age 
(Figure 3A & 3B; p = 0.090), and a decrease in p-PKC 
in males between nine months and twelve months of 
age (Figure 3A & 3B; p = 0.079). Larger sample sizes 
may elucidate these findings.  
 
Hippocampal whole cell analysis also demonstrated a 
significant increas of PKC concentration within female 
rats between four weeks of age and three months of age 
(Figure 3A & 3C; p = 0.037).  In addition to age-depen-
dent alterations, there were also significant PKC con-
centration differences between genders at four weeks of 
age (Figure 3A & 3D; p <0.001), nine months of age 
(Figure 3A & 3D; p = 0.020), and twelve months of age 
(Figure 3A & 3D; p = 0.015) with males experiencing 
higher concentrations at all time points.  
 
Both gender and age-dependent changes were noted for 
cx43 (Figure 3A, 3E, & 3F).  Female rats experienced a 
significant increase in cx43 from four weeks of age to 
twelve months of age (Figure 3A & 3E; p = 0.022), and 
female rats also demonstrated significantly higher 
concentrations of cx43 at twelve months of age 
compared to their male counterparts (Figure 3A & 3F; p 
= 0.002). There were no significant alterations noted 
within p-cx43, p-ERK, or ERK concentrations across 
gender or age (Figure 3A, 3G-I). A graphical depiction 
of this data can be seen in Figure 3. 
 
Hippocampus - mitochondrial isolation 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within hippocampal 
mitochondria over time and between genders, mito-
chondria were isolated from the hippocampus of male 
and female rats at 4 timepoints throughout their lifespan 
(4 weeks, 3 months, 9 months, and 12 months of age; n 
= 3-4/gender/age). A significant increase in p-cx43 was 
found for both genders from four weeks of age to three 
months of age (Figure 4A & 4B; male p = 0.031, female 
p = 0.001). This increase was then followed by a 
significant decrease of p-cx43 from nine months of age 
to twelve months of age (Figure 4A & 4B; p = 0.009). 
Additionally, female rats possessed a significantly 
higher concentration of p-cx43 at nine months of age 
compared to their male counterparts (Figure 4A & 4C; p 
< 0.001).   
 
Isolated mitochondria from the hippocampus also 
showed altered expression of cx43.  There was a 
significant increase in cx43 from four weeks of age to 
three months of age (Figure 4A & 4D; p = 0.012).  
Similar to the alterations found with p-cx43, there was a 
significant decrease in mitochondrial cx43 at twelve 
months of age (Figure 4A & 4D; p = 0.017); however, 
this was only seen in females.  There was a significant 
difference between male and female cx43 expression at 
nine months of age, with female rats having 
significantly more cx43 when compared to their male 
counterparts (Figure 4A & 4E; p = 0.003).   
 
Although not significantly different, the estrogen 
receptor beta displayed a decreasing trend between nine 
and twelve months of age (Figure 4A & 4B; p = 0.089).  
The concentration of PKC remained relatively constant 
regardless of age or gender (Figure 4A & 4G). A 
graphical depiction of this data is presented in Figure 4. 
 
Amygdala – whole cell 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within the amygdala over 
time and between genders, whole cell lysate proteins 
were isolated from the amygdala of male and female 
rats at 3 timepoints throughout their lifespan (4 weeks, 3 
months, and 9 months of age; n = 3/gender/age). No 
animals at the 12-month timepoint were analyzed for 
this brain region (Figure 5A-H).  Although there were 
not any significant differences in this study, it is 
possible that differences exist given larger sample sizes 
or at the later, aged timepoint that was not available for 
this study in this region. A graphical depiction of these 
findings can be seen in Figure 5. 
 
Amygdala – mitochondrial isolation 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within the mitochondria 
from the amygdala over time and between genders, 
mitochondria were isolated from the amygdala of male 
and female rats at 3 timepoints throughout their lifespan 
(4 weeks, 3 months, and 9  months  of  age;  n = 3/gender/ 
age). Although whole cell analysis for the amygdala did 
not show any significance, mitochondrial isolation for 
the amygdala demonstrates age-dependent and gender-
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dependent alterations.  There was a significant decrease 
in the concentration of PKC between four weeks of age 






















































Additionally, 9-month female rats had significantly 
higher mitochondrial PKC when compared to their male 





















































Figure  4.  Signaling  downstream  of  estrogen  in  the  mitochondria  of  the  hippocampus  across  age  and  gender.
Representative western blots for each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction
of  the  fold change  for p‐cx43 comparing age  (B), p‐cx43 comparing gender  (C), cx43 comparing age  (D), cx43 comparing gender  (E),
estrogen receptor beta (F), PKC (G), ATP synthase (H). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months of age; 9M = 9 months of
age; 12M = 12 months of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05. Pink * = p<0.05 for females only. 
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decreasing PKC in male rats from four weeks of age to 
nine months of age was also noted (Figure 6A & 6C; p 






















































A trend for increased mitochondrial p-cx43 between 
four weeks of age to nine months of age was also found 
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differences and observed trends, it was noted that the 
concentration of mitochondrial cx43 and estrogen 
receptor beta did not significantly change in the 
amygdala and did not seem to be age-dependent or 
gender-dependent (Figure 6A, 6B, 6F).  All of this data 



















































Corpus callosum – whole cell 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within the corpus 
callosum over time and between genders, whole cell 
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of male and female rats at 4 timepoints throughout 
their lifespan (4 weeks, 3 months, 9 months, and 12 
months of age; n = 3/gender/age). The corpus callosum 
was yet another brain region that demonstrated sig-
nificant age-dependent and  gender-dependent changes 


















































months of age had significantly higher p-PKC than 
their male counterparts (Figure 7A & 7B; p = 0.014).  
There was also a significance decrease in the con-
centration of p-ERK between nine months of age and 
twelve months of age (Figure 7A & 7C; males, p = 
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When comparing genders, male rats experienced 
notably higher concentrations of p-cx43 compared to 
the female rats at four weeks of age (Figure 7A & 7D; p 
= 0.047).  Although statistical significance was not 
demonstrated, the data indicated that gender differences  
may exist within p-ERK at three months of age and nine 
months of age given a larger sample size (Figure 7A & 
7C; p =0.058 and p = 0.098, respectively).  This may 
also hold true for male rats between four weeks of age 
and nine months of age, as the concentration  of  p-ERK  
increased within this time period (Figure 7A & 7C; p = 
0.057).   
 
No significant differences were noted for PKC, ERK, 
and cx43 when comparing gender and age (Figure 7A, 
7E, 7F, & 7G).  A graphical depiction of this data is 
presented in Figure 7.   
 
Corpus callosum - mitochondrial isolation 
  
In order to determine whether signaling downstream of 
the estrogen receptor changed within corpus callosum 
mitochondria over time and between genders, 
mitochondria were isolated from the corpus callosum of 
male and female rats at 4 timepoints throughout their 
lifespan (4 weeks, 3 months, 9 months, and 12 months 
of age; n = 3/gender/age). Unlike the whole cell 
analysis, the mitochondrial isolation analysis for the 
corpus callosum only demonstrated age-dependent 
changes.  No significant gender differences were found.  
PKC significantly decreased in both genders between 
nine months of age and twelve months of age (Figure 
8A & 8B; male, p = 0.005; female, p = 0.002).  A 
similar trend was noted in the concentration of p-cx43, 
which also seemed to be decreased between nine 
months of age and twelve months of age (Figure 8A & 
8C; p = 0.059), although not statistically significant in 
this study.  The concentration of estrogen receptor beta 
and cx43 did not significantly vary throughout the aging 
process or across gender lines (Figure 8A, 8D, & 8E).  
A graphical depiction of these findings can be 
visualized in Figure 8. 
 
Cerebellum – whole cell 
 
In order to determine whether signaling downstream of 
the estrogen receptor changed within the cerebellum 
over time and between genders, whole cell lysate 
proteins were isolated from the cerebellum of male and 
female rats at 4 timepoints throughout their lifespan (4 
weeks, 3 months, 9 months, and 12 months of age; n = 
3/gender/age). Cerebellar whole cell analysis illuminat-
ed that the concentration of cx43 is age-dependent in 
this region of the brain.  It  has  been  commonly  known  
 
that cx43 decreases with age; therefore, the decrease in 
cx43 in both genders between four weeks of age and 
nine months of age, although not statistically sig-
nificant, was not surprising. However, it was surprising 
to find that within the cerebellum cx43 significantly 
increased between nine and twelve months of age 
(Figure 9A & 9B; p = 0.017).   
 
While the concentration of p-PKC did not show 
significant differences, it did reveal the possibility of 
gender differences at nine months of age, where males 
experienced increased levels of this protein (Figure 9A 
& 9C; p = 0.058).  There is also the possibility that 
males have decreased p-PKC between nine months of 
age and twelve months of age, although again the 
threshold for statistical significance was not obtained 
(Figure 9A & 9C; p = 0.054).    No significant differen-
ces were noted in cerebellar PKC, p-ERK, ERK, and p-
cx43 regardless of age or gender (Figure 9A, 9C, 9D, 
9E, & 9G).  Data and controls are depicted graphically 
in Figure 9. 
 
Cerebellum – mitochondrial isolation 
 
In order to determine whether signaling downstream of 
the estrogen receptor changed within cerebellum 
mitochondria over time and between genders, mito-
chondria were isolated from the cerebellum of male and 
female rats at 4 timepoints throughout their lifespan (4 
weeks, 3 months, 9 months, and 12 months of age; n = 
3/gender/age). Contrary to the cerebellar whole cell 
analysis, significant age-dependent and gender-
dependent alterations were found in the mitochondria of 
the cerebellum.  Females had significantly higher 
mitochondrial estrogen receptor beta when compared to 
age-matched males at three months of age (Figure 10A 
& 10B; p = 0.041) and at nine months of age (Figure 
10A & 10B; p = 0.018). Similarly, females had 
significantly higher PKC when compared to age-
matched males at nine months of age (Figure 10A & 
10C; p = 0.030) and at twelve months of age (Figure 
10A & 10C; p = 0.015). 
 
Beyond the gender-related changes, age-related 
changes were seen within the concentration of p-cx43.  
P-cx43 was significantly decreased between four 
weeks and twelve months of age (Figure 10A & 10D; 
p = 0.028), as well as between three and twelve 
months of age (Figure 10A & 10D; p = 0.015).  In the 
cerebellum, the only protein investigated that did not 
significantly vary throughout the aging process or 
between genders was cx43 (Figure 10A & 10E).  A 
graphical depiction of these findings can be visualized 
in Figure 10. 
 





















































A summary table indicating significant differences and 
trends for each brain region and signaling protein data 



















































lysate protein concentration differences between males 
and females for each brain region. Table 2 displays 
significant differences in mitochondrial protein con-
centration differences between males and females for 
each brain region. Table 3 summarizes significant 
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changes with age in the whole cell lysate protein 
concentrations for each brain region regardless of gen-
der. Table 4 summarizes significant changes with age in 



















































less of gender. Statistically significant differences, 
p<0.05, are indicated in yellow.  Non-significant trends 





















































































































































































































































































p-PKC    4wk M>F 12mo F>M 9mo M>F 12mo F>M
ERK     
p-ERK   9mo M>F  3mo M>F  12mo M>F 9mo M>F
cx43  12mo F>M   
p-cx43   4wk M>F  
n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant  
Table 2. Summary of significant mitochondrial protein changes with gender. 
 Cortex Hippocampus Amygdala Corpus Callosum Cerebellum
ER-beta 4wk F>M    3mo F>M9mo F>M
PKC   9mo F>M  9mo F>M12mo F>M
cx43  9mo F>M    
p-cx43 12mo M>F 9mo F>M    
n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant  
Table 3. Summary of significant whole cell protein changes with Age regardless of gender. 
 Cortex Hippocampus Corpus Callosum Cerebellum 
PKC  Inc 4wk-3mo   
p-PKC  Dec 9mo-12mo  Dec 9mo-12mo
ERK     
p-ERK   Inc 4wk-9mo  
Dec 9mo-12mo
cx43  Inc 4wk-12mo  Dec 4wk-9mo 
Inc 9mo-12mo
p-cx43     
n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant 
Table 4. Summary of significant whole cell protein changes with Age regardless of gender. 
 Cortex Hippocampus Amygala Corpus Callosum Cerebellum
ER-beta  Dec 9mo-12mo    
cx43 Inc 4wk-9mo Inc 4wk-3mo    Dec 9mo-12mo F
p-cx43 Inc 4wk-3mo Inc 4wk-3mo Inc 4wk-9mo Dec 9mo-12mo Dec 4wk-12moDec 9mo-12m Dec 3mo-12mo
PKC   Dec 4wk-3mo Dec 9mo-12mo  Dec 4wk-9mo
n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant 
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DISCUSSION 
 
Females have a longer life expectancy than males in 
mammals, including humans [29-30]. Because this 
prolonged lifespan is not exclusive to humans, socio-
economic factors cannot be entirely to blame. This hints 
that a gender-specific biological differences, such as 
hormone regulation, may contribute to this phenome-
non. Similarly, epidemiological studies have shown that 
there are gender- and age-dependent factors that 
correspond to the incidence and/or severity of various 
age-related neurodegenerative diseases. For example, 
males have an earlier onset and increased prevalence for 
Parkinson’s disease (PD) than age-matched females 
[31]. Likewise, females have been shown to have an 
increase in neuroprotection from stroke severity pre-
menopause [7-9]. These gender-related studies have led 
to the hypothesis that the positive effects of estrogen on 
cellular processes may be one mechanism by which 
females have early life protection from neuro-
degenerative symptoms, and ultimately a longer life-
span. The mechanism(s) by which estrogen is neuro-
protective is unknown; however, it has been well 
documented that estrogen can modify immune com-
petence, reactive oxygen species (ROS) production, and 
telomere maintenance [32-33].  
 
The loss of estrogen midlife, post-estrus, may argue that 
this neuroprotection declines at menopause. In fact, 
evidence does show that post-menopausal women have 
a higher incidence of Alzheimer’s Disease (AD) than 
men, as well as a faster cognition decline after disease 
onset [34-35]. Furthermore, the severity of stroke 
increases dramatically post menopause [7-9].  In addi-
tion, Bake S & Sohrabji F. showed that the increased 
Blood Brain Barrier permeability in aged, post-estrus 
rats could not be rescued with estrogen replacement 
therapy as it could in young females post ovarectomy 
[36] – suggesting that there are alterations post-estrus 
that do not allow the cells to respond to estrogen 
replacement therapy as in younger animals. These data 
suggest that loss of estrogen can indeed decrease neuro-
protection in females. Since females tend to live longer, 
this may seem counter-intuitive. However, longer 
lifespan has also been correlated to later stage 
menopause [37], which may suggest that the lifetime 
cumulative exposure to estrogen exerts a long-lasting 
effect. Altogether, we suggest that gender and hormone 
regulation are biological variables that may be impor-
tant when considering both normal aging and age-
associated neurodegenerative diseases. 
 
The mechanism(s) for hormone-associated neuro-
protection and the dramatic decline in females at 
menopause is yet unknown. The current study examined 
cell signaling molecules downstream of the estrogen 
receptor-beta over the lifespan of both male and female 
rats to attempt to elucidate significant changes that 
occur during the post-estrus change. 
  
We propose that gender-dependent hormone 
fluctuations with age may be one factor that determines 
why neuroprotection differs between males and 
females, which can be more pronounced during the non-
estrus, or menopausal stage of female life. The decline 
in estradiol noted in the aged (9-month and 12-month 
female rats) corresponded with significant changes in 
PKC, p-PKC, p-ERK and cx43 protein concentrations 
throughout the brain, but most notably within the 
hippocampus of female rats during those timeframes.  
Decreased expression of PKC isoforms with age in the 
hippocampus and frontal cortex have been linked to 
significant declines in spatial memory [6]. Furthermore, 
in a 2016 review Orellana JA et al. expound upon the 
necessity of cx43 for memory consolidation throughout 
the brain [38]. However, these previous studies did not 
differentiate between gender. Our findings show signifi-
cant gender-dependent alterations within both PKC and 
cx43 within the hippocampus and cortex. Moreover, 
given the historical links of PKC and cx43 to memory 
during neurodegeneration and aging, the correlations 
provided from this study indicate the possibility of 
linking these pathway changes to the memory 
alterations noted and further explain the gender-
dependent changes at this age in females. Further expe-
riments to define whether a decline in memory is 
hormone-dependent in females at this time are planned. 
 
Data from this study also correlates the decrease in 
estradiol levels with significant differences between 
male and female cx43 and p-cx43 in hippocampal 
mitochondria, and mitochondrial PKC concentrations 
within the cerebellum. Mitochondrial PKC and cx43 
have been previously shown to regulate oxidative 
phosphorylation in the mitochondria [39-41]; therefore, 
an age-dependent decline in mitochondrial cx43 and p-
cx43 would be indicative of non-optimal mitochondrial 
respiration often found in neurodegenerative diseases. 
This is consistent with previous reports that showed 
attenuation of oxidative stress and mitochondrial dys-
function were sufficient to improve the memory in a 
mouse model for Alzheimer’s Disease [42]; and 
suggests that the loss of hormones at this critical time of 
life may contribute to the increased cognitive and 
learning and memory deficit severity noted in this 
population due to mitochondrial signaling alterations.   
 
Mitochondrial cx43 and p-cx43 significantly increased 
as the rats aged between the adolescent 4-week age and 
more adult 3-month to 12-month ages in the cortex and 
hippocampus regardless of gender. Significant 
decreases in these protein concentrations were not 
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found until the 9 and 12-month post-estrus age in 
female rats, and this decrease was gender-specific. It is 
interesting to note here that these alterations in cx43 and 
p-cx43, which both correspond to the ages of neuro-
protection and memory development early in life and 
decline with age, are only found in the mitochondrial 
fractions and were not found to be significantly dif-
ferent in the whole cell lysates.  Similarly, PKC from 
the mitochondrial isolates but not whole cell lysates 
also significantly decreased in the corpus callosum at 
the 9 and 12-month, aged timepoint regardless of 
gender.  These discoveries are important because while 
PKC and cx43 have been associated with age and 
memory loss, the distinction between the mito-
chondrial function and that of signaling elsewhere in 
the cell is novel.  
 
PKC and cx43 are both known down-stream targets of 
estrogen and are known to regulate mitochondrial 
respiration. These proteins experienced expression 
changes throughout the aging process, some of which 
were gender-dependent.  These expression changes 
varied based on the localization of the protein, within 
whole cell lysate or isolated mitochondria, suggesting 
that the altered protein concentration is likely secondary 
to epigenetic changes rather than genetic changes. 
Finding statistical significance with such a small sample 
size using an in vivo rat model elucidates just how 
dramatic some of these alterations are.   
 
While the current study does not focus upon the Blood 
Brain Barrier, disruption of this barrier has been 
correlated to normal aging as well as many neuro-
degenerative diseases. Mitochondrial dysfunction has 






















and Blood Brain Barrier disruption. Therefore, we 
propose a potential mechanism by which loss of 
estrogen post estrus can result in decreased mito-
chondrial function and increased permeability of the 
Blood Brain Barrier (Figure 11). In this model, loss of 
estrogen post menopause results in a reduction of pPKC 
and p-cx43 leading to decreased mitochondrial function, 
increased ROS production and ultimately an increase in 
Blood Brain Barrier permeability. 
 
Not only do each of the brain regions investigated 
demonstrate unique age-dependent alterations, but they 
also all demonstrate gender-dependent alterations.  
Although numerous cellular signaling pathways may be 
involved in these alterations, signaling downstream of 
the estrogen receptor-beta seems to have a pronounced 
role.  Several of the proteins involved within this signal-
ing cascade experienced expression changes throughout 
the aging process.  Of the proteins examined, only ERK 
remained relatively constant throughout all age groups, 
genders, and brain regions.   
 
Data from this study also correlates the decrease in 
estradiol levels with significant differences between 
male and female cx43 and p-cx43 in hippocampal 
mitochondria, and mitochondrial PKC concentrations 
within the cerebellum. This fits with previous reports 
where attenuation of oxidative stress and mito-
chondrial dysfunction were sufficient to improve the 
memory in a mouse model for Alzheimer’s Disease 
[42]; and suggests that the loss of hormone at this 
critical time of life may contribute to the increased 
cognitive and learning and memory deficit severity 
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Aging is an extremely intricate, complex process that 
involves changes in a variety of genes, protein signaling 
pathways, and epigenetic factors. It is noted that we 
only examined a small subset of estrogen-responsive 
proteins; however, each brain region studied did 
demonstrated unique age-dependent and gender-depen-
dent signaling protein concentration alterations. These 
significant protein concentration changes will allow for 
focused region-specific future studies that will help 
unravel mechanisms behind neuroprotection and 
memory changes with age and gender. 
 
MATERIALS AND METHODS 
 
Animals and tissue harvesting 
 
Forty-seven Sprague Dawley rats were obtained 
(Charles River Laboratories) and were split into four 
age groups (4 weeks, 3 months, 9 months, and 12 
months of age), for both males and females. Each of 
these groupings were repeated so that tissue could be 
isolated for both total cellular analysis and for mito-
chondrial fractionalization studied (n=3-4 per group).   
 
Blood was collected from each animal after euthanasia 
but before cardio-perfusion via a cardiac draw. Elisa 
assays for estradiol levels were performed to correlate 
the age-associated decline in estradiol levels and to 
assess post-estrus status in 9-12 month old females (data 
not shown). Each rat was euthanized using an intra-
peritoneal injection of phenobarbital.  A foot pinch or 
tail pinch test was performed to ensure no withdrawal 
reflex was elicited, and to confirm that the rat had been 
appropriately anesthetized.  Cardio-perfusion was then 
performed using ice cold 1× phosphate buffered saline 
(PBS).  Brain regions were dissected, flash frozen in 
liquid nitrogen, and stored at -80°C.   
 
Tissue homogenization - whole cell 
 
Tissue samples were homogenized in lysis buffer 
containing 1% phosphatase inhibitor cocktail 2, 1% 
phosphatase inhibitor cocktail 3, 1% pheny-
lmethylsulfonyl fluoride, and 4% cOmplete EDTA-free 
protease inhibitor cocktail. They were then centrifuged 
for ten minutes (12,000 rpm at 4°C), and the pellet and 




This mitochondrial isolation procedure is a modified 
version of the mitochondrial isolation protocol provided 
by Cold Springs Harbor Laboratory Press (Cold Spring 
Harb Protoc; doi:10.1101/pdb.prot080002).  Samples 
were incubated in RBS hypobuffer containing 1% 
phosphatase inhibitor cocktail 2, 1% phosphatase 
inhibitor cocktail 3, 1% phenylmethylsulfonyl fluoride, 
and 4% cOmplete EDTA-free protease inhibitor 
cocktail for five minutes before being homogenized for 
ten minutes using a micro tube homogenizer.  Immedi-
ately after homogenization, 2.5×MS homogenization 
buffer was added to each sample.  The samples were 
mixed by inversion five times, transferred to a 1.5 mL 
microcentrifuge tube, centrifuged for five minutes 
(1,300 g at 4°C), and the supernatant was transferred to 
a new 1.5 mL microcentrifuge tube.  This process was 
performed three times, transferring the supernatant to a 
new 1.5 mL microcentrifuge tube each time.  After the 
third round of centrifugation supernatant was then 
centrifuged for fifteen minutes (12,000 g at 4°C).  The 
remaining supernatant after this final centrifugation was 
transferred to a new 1.5 mL microcentrifuge tube.  The 
pellet from the final centrifugation was resuspended 
with 100 µL of 1×MS homogenization buffer (1% 
phosphatase inhibitor cocktail 2, 1% phosphatase 
inhibitor cocktail 3, 1% phenylmethylsulfonyl fluoride, 
and 4% cOmplete EDTA-free protease inhibitor 
cocktail).  The three pellets, the final supernatant, and 
the resuspended sample were all frozen and stored at -




A BCA protein assay was performed to determine the 
total protein concentration of each sample using a 
Pierce BCA Assay Protein Kit. Western blots were 
performed at described previously [43].  The primary 
antibodies that were used throughout this study were: 
1:1,000 Anti-Phospho-PKC alpha (Ser657) goat 
polyclonal (Santa Cruz Biotechnologies, Product 
number: sc-12356), 1:1,000 Anti-PKC alpha rabbit 
polyclonal (Cell Signaling Technology, Product 
number: 2056S), 1:1,000 Anti-Phospho-p44/42 ERK 
(Thr202/Tyr204) XP rabbit monoclonal (Cell Signaling 
Technology, Product number: 4370S), 1:1,000 Anti-
p44/42 ERK (L34F12) mouse monoclonal (Cell 
Signaling Technology: Product number: 4696S), 1:500 
Anti-Estrogen receptor beta rabbit polyclonal (Invitro-
gen, Product number: PA1-310B), 1:1,000 Anti-
Phospho-Connexin 43 (Ser368)(D6W8P) rabbit 
monoclonal (Cell Signaling Technology, Product 
number: 52559S), 1:8,000 Anti-Connexin 43 (GJA1) 
rabbit polyclonal (Abcam, Product number: ab11370), 
1:1,000 Anti-ATP5B (R-20) goal polyclonal (Santa 
Cruz Biotechnology, Product number: SC-16689), and 
1:5,000 Anti-Beta-actin (13E5) rabbit monoclonal (Cell 
Signaling Technology, Product number: 4970S).  The 
secondary antibodies that were used throughout this 
study were: 1:4,000 Donkey Anti-Goat Horse Radish 
Peroxidase (HRP) conjugated IgG (Santa Cruz 
Biotechnologies, Product number: sc-2033), 1:5,000 
Anti-Mouse HRP-conjugated IgG (Cell Signaling 
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Technology, Product number: 7076S), and 1:5,000 or 
1:10,000 Anti-Rabbit HRP-conjugated IgG (Cell 
Signaling Technology, Product number: 7074S).   
 
Each membrane utilized two processes to verify even 
protein loading to each well.  All blots were stained 
with Ponceau as a total protein loading control. For 
mitochondrial isolation, membranes were also probed 
with 1:1,000 Anti-ATP5B antibody. For whole cell 




X-ray film was scanned using a HP Scanjet 3970, 
grayscale coloring, and a resolution of 1200 dpi. Bands 
were quantified using ImageJ Software, and band 
intensities were normalized as a ratio to corresponding 
load control values.  A two-way ANOVA with Tukey 
Post-hoc testing was performed to determine statistical 
significance using SigmaPlot v14.0.  Line graphs were 
created using GraphPad Prism 7 and demonstrate the 
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SUPPLEMENTARY MATERIAL  
 
  Supplementary Table 1. 
Aging Stage Rat Age Human Age 
Adolescent 0-6 weeks 0-12 years 
Puberty 5-8 weeks 12-18 years 
Young Adult 8 weeks – 11 months 18-40 years 
Middle-Aged Adult 11-15 months 50-60 years 
Elderly Past 15 months Past 60 years 
